SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genaissance Pharmaceuticals (GNSC)
An SI Board Since September 2000
Posts SubjectMarks Bans Symbol
183 6 0 GNSC
Emcee:  Jim Oravetz Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
183Posted in CLDA thread: Message 22663025 "Going forward, a key objective isJim Oravetz-7/27/2006
182CLDA deserves a thread--I can't find one, anybody seen a Clinical Data threMike McFarland-2/5/2006
181Clinical Data Completes Acquisition of Genaissance Pharmaceuticals Clinical DatJim Oravetz-10/10/2005
180News On Genaissance (GNSC) Now Under (CLDA) DOW JONES NEWSWIRES October 7, 2005 Jim Oravetz-10/10/2005
179Genaissance Pharmaceuticals And Ipsogen Announce Cancer Biomarker Research AgreeJim Oravetz-9/12/2005
178Genaissance Pharma 2Q Loss 12c/Shr Vs 26c DOW JONES NEWSWIRES August 9, 2005 9:4Jim Oravetz-8/9/2005
177Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement witnigel bates-7/19/2005
176Genaissance to fetch $56 million in stock Damian J. Troise , Register Staff Jim Oravetz-6/22/2005
175Clinical Data To Buy Genaissance Pharmaceuticals; Combined Co To Deliver IndustrJim Oravetz-6/21/2005
174Genaissance test rules out disorder in Schiavo autopsy Abram Katz , Register SJim Oravetz-6/20/2005
173Genaissance Reports First Quarter 2005 Results NEW HAVEN, Conn., May 3 /PRNewswnigel bates-5/3/2005
172Genaissance and ParAllele BioScience Sign License and Co-Marketing Agreement Wednigel bates-4/6/2005
171Well maybe glgc will finally pull ahead; and for whatever reason, yahoo chart quMike McFarland-3/29/2005
170FOOTNOTES: Recent Going-Concern Statements DOW JONES NEWSWIRES March 28, 2005 5:Jim Oravetz-3/29/2005
169Eight weeks later, nothing has changed, same marketcaps, and neither seems to Mike McFarland-3/23/2005
168Genaissance Comments on FDA Guidance on Pharmacogenomics Tuesday March 22, 12:00nigel bates-3/22/2005
167It doesn’t sound like there’s much upside in this deal for GNSC other than the pDewDiligence_on_SI-3/10/2005
166Monsanto Teams With Biotech Co, USDA To Map Soybean's DNA DOW JONES NEWSWIREJim Oravetz-3/10/2005
165gnsc lists net assets of -5M and carries a MC of 51m. That seems exceedingly rMike McFarland-1/27/2005
164<i>interesting....</i> enough to knock 10% of the price. ;-) Tempnigel bates-1/26/2005
163<i>I don't follow gnsc, but this looks interesting.</i> Genaisskeokalani'nui-1/26/2005
162Genaissance Allowed Patent for Novel Methods to Correlate Genetics With Drug Safnigel bates-1/4/2005
161Genaissance Identifies Genetic Markers Implicated in Fatal Side Effects Of Schiznigel bates-12/20/2004
160Genaissance Pharmaceuticals Updates Guidance for 2004 Revenue Thursday October 2Jim Oravetz-10/21/2004
159SemiOT: Now on his own, Genaissance founder Ruano has big plans for thinking smaJim Oravetz-10/7/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News